Results for “”

Entry Author Date Location
$5.8B for Nothing: AbbVie Shelves Stemcentrx Drug After Latest Flop 08/29/19 Detroit Ann Arbor
Ring Confirms Report, Says It Works With More Than 400 Police Agencies 08/28/19 Seattle
Celgene Adds Cell Therapies From Immatics With Bristol Sale in Sight 08/28/19 New York
ThoughtSpot Nabs $248M for Accessible Analytics, Nears $2B Valuation 08/28/19 San Francisco
Ionis Gets $25M From GSK for Experimental Hepatitis B Program 08/27/19 San Diego
NuTonomy Switches to Chrysler For More Elbow Room in Self-Driving Cars 08/27/19 Boston
Seattle Startup Funding Tidbits: Blokable, Zenoti, PTO Exchange 08/27/19 Seattle
Celgene to Sell Blockbuster Drug to Amgen for $13B to Close BMS Deal 08/26/19 New York
For GW Pharma CEO Justin Gover, The CBD Trend Started 20 Years Ago 08/26/19 San Diego
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.) 08/26/19 National
Why Amazon’s Ascent Spells Bad News for Mall Food Courts 08/23/19 Seattle
VMware: “We Bought Carbon Black for $2.1B!” Analysts: “Oh… Why?” 08/23/19 Boston
GSK’s Cancer Comeback Continues With Data for Multiple Myeloma Drug 08/23/19 National
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
Boston Tech Watch: Epstein, MIT Media Lab, Carbon Black, JRNI & More 08/23/19 Boston
New BC Biotech Chinook Reels in $65M to Tackle Kidney Disease 08/22/19 National
VMware Dropping $4.8B to Buy Carbon Black, Pivotal Software 08/22/19 Boston
Retrophin Sinks as Drug “Pharma Bro” Martin Shkreli Co-Invented Fails 08/22/19 San Diego
Healthcare’s Future is Telemedicine & AI, But Will Everyone Benefit? 08/22/19 Boston
Splunk To Pay $1B For SaaS App Monitoring Firm SignalFx 08/21/19 San Francisco
Ford’s Autonomic Connects EV Maker Ayro to Its Mobility Cloud 08/21/19 San Francisco
Xcelerate at Biotech Week Boston Discount Ticket Sale Ends Friday 08/21/19 National
Oncorus Adds $79.5M to Steer Cancer-Fighting Virus to Human Testing 08/21/19 Boston
Elanco’s $7.6B Deal With Bayer Bolsters Pets, Farm Animals Footprint 08/20/19 Indiana
Startup Blooma Launches With $2.75M to Digitize Commercial Lending 08/20/19 San Diego
FDA Rejects Sarepta’s Second Duchenne Drug, Citing Safety Concerns 08/19/19 Boston
Enterprise Software Startup Ally Nabs $8M to Support Global Growth 08/19/19 Seattle
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs 08/16/19 New York
AbbVie’s Successor to Humira Wins FDA OK for Rheumatoid Arthritis 08/16/19 National
Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More 08/16/19 National
Page 3 of 1950 « previous page · next page »